Cancer BiologyBloodPeer-reviewed
CD38 biallelic loss is a recurrent mechanism of resistance to anti-CD38 antibodies in multiple myeloma.
Benjamin T. Diamond, Linda Banovic Baughn, Mansour Poorebrahim…·Francesco Maura
This study identifies biallelic CD38 loss as a mechanism of resistance to anti-CD38 antibodies in multiple myeloma, with specific mutations affecting antibody efficacy.
18 citationstop 1%